Suppressive effect of transforming growth factor β1 on the recurrence of experimental melanin protein-induced uveitis: Upregulation of ocular interleukin-10

Clinical Immunology and Immunopathology

Volumn 81, Issue 1, 1996, Pages 55-61

  Li, Qian ^a   Sun, Bing ^a   Dastgheib, Kourosh ^a   Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MELANIN; SALMONELLA ENDOTOXIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; UVEITIS;

EID: 0030271925     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0157     Document Type: Article

References (33)

1. 1. Broekhuyse, R. M., Kuhlmann, E. D., Winkens, H. J., and Van Vugt, H. M., Experimental autoimmune anterior uveitis (EAAU), a new form of experimental uveitis. I. Induction by a detergent-insoluble intrinsic protein fraction of the retinal pigment epithelium. Exp. Eye Res. 52, 465-474, 1991.
2. 2. Chan, C.-C., Hikita, N., Dastgheib, K., Whitcup, S. M., Gery, I., and Nussenblatt, R. B., Experimental melanin protein induced uveitis in the Lewis rat: Immunopathologic processes. Ophthalmol. 101, 1275-1280, 1994.
3. 3. Bora, N. S., Kim, M. C., Kabeer, N. H., Simpson, S. C., Tandhasetti, M. T., Cirrito, T. P., Kaplan, A. D., and Kaplan, H. J., Experimental autoimmune anterior uveitis: Induction with melanin-associated antigen from the iris and ciliary body. Invest. Ophthalmol. Vis. Sci. 36, 1056-1066, 1995.
4. 4. Broekhuyse, R. M., Kuhlmann, E. D., and Winkens, H. J., Experimental autoimmune anterior uveitis (EAAU). II. Dose-dependent induction and adoptive transfer using a melanin-bound antigen of the retinal pigment epithelium. Exp. Eye Res. 55, 401-411, 1992.
5. 5. Kim, M. C., Kabeer, N. H., Tandhasetti, M. T., Cirrito, T. P., Kaplan, H. J., and Bora, N. S., Immunohistochemical studies on melanin associated antigen (MAA) induced experimental autoimmune anterior uveitis (EAAU). Curr. Eye Res. 14, 703-710, 1995.
6. 6. Li, Q., Dastgheib, K., Luyo, D., Egwuagu, C., Nussenblatt, R. B., and Chan, C-C., Expression of Transforming growth factor β1 in experimental melanin protein induced uveitis and experimental autoimmune uveitis. In "Advances in Ocular Immunology" (R. B. Nussenblatt, S. M. Whitcup, R. R. Caspi, and I. Gery, Eds.), pp. 99-102, Elsevier Science B. V., Amsterdam, 1994.
7. 7. Roberts, A. B., and Sporn, M. B., The Transforming Growth Factor-βs. In "Peptide Growth Factors and Their Receptors" (J. F. Battey, K. Arai, M. B. Sporn, and A. B. Robert, Eds.), pp. 419-472, Springer-Verlag, New York, 1990.
8. 8. Massague, J., Cheifetz, S., Boyd, F. T., and Andres, J. L., TGF-β receptors and TGF-β binding proteoglycans: Recent progress in identifying their functional properties. Ann. N.Y. Acad. Sci. 593, 59-72, 1990.
9. 9. Lutty, G., Ikeda, K., Chandler, C., and McLeod, D. S., Immunohistochemical localization of transforming growth factor-β in human photoreceptors. Exp. Eye Res. 10, 61-74, 1991.
10. 10. Wilson, S. E., He, Y. G., and Lloyd, S. A., EGF, EGF receptor, Basic FGF, TGFβ1, and IL-1α mRNA in human corneal epithelial cells and stromal fibroblasts. Invest. Ophthalmol. Vis. Sci. 33, 1756-1765, 1992.
11. 11. Pasquale, L. R., Dorman-Pease, M. E., Lutty, G. A., Quigley, H. A., and Jampel, H. D., Immunolocalization of TGFβ1, TGFβ2, and TGFβ3 in the anterior segment of the human eye. Invest. Ophthalmol. Vis. Sci. 34, 23-30, 1993.
12. 12. Connor, T. B., Jr., Roberts, A. B., Sporn, M. B., Danielpour, D., Dart, L. L., Michels, R. G., de Bustros, S., Enger, C., Kato, H., Lansing, M., Hayashi, H., and Glasser, B. M., Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J. Clin. Invest. 83, 1661-1666, 1989.
13. 13. Lucas, C., Walick, S., Fendly, B. M., Figari, I., and Palladino, M. A., TGF-β: A possible autocrine immune regulator. Ciba Found. Symp. 157, 98-114, 1991.
14. 14. Wahl, S. M., McCartney-Francis, N., and Mergenhagen, S. E., Inflammatory and immunomodulatory roles of TGF-β. Immunol. Today 10, 258-261, 1989.
15. 15. Wilder, R. L., Lafyatis, R., Roberts, A. B., et al., Transforming growth factor-β in rheumatoid arthritis. Ann. N.Y. Acad. Sci. 593, 197-207, 1990.
16. 16. Peng, B., and Shichi, H., Ciliary body in experimental autoimmune uveitis: Tissue repair and immunoreactivity of extracellular matrix substances. Curr. Eye Res. 11, 1087-1097, 1992.
17. 17. Brandes, M. E., Allen, J. B., Ogawa, Y., and Wahl, S. M., Transforming growth factor β1 suppresses acute and chronic arthritis in experimental animals. J. Clin. Invest. 87, 1108-1113, 1991.
18. 18. Gregorian, S. K., Lee, W. P., Beck, L. S., Rostami, A., and Amento, E. P., Regulation of experimental autoimmune neuritis by transforming growth factor-β1. Cell. Immunol. 156, 102-112, 1994.
19. 19. Johns, L. D., Flanders, K. C., Ranges, G. E., and Sriram, S., Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J. Immunol. 147, 1792-1796, 1991.
20. 20. Racke, M. K., Dhib-Jalbut, S., Cannella, B., Albert, P. S., Raine, C. S., and McFarlin, D. E., Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J. Immunol. 146, 3012-3017, 1991.
21. 21. Gazzinelli, R. T., Brezin, A., Li, Q., Nussenblatt, R. B., and Chan, C-C., Toxoplasma gondii: Acquired ocular toxoplasmosis in the murine model, protective role of TNF-α and IFN-γ. Exp. Parasitol. 78, 217-219, 1994.
22. + T cells. Immunol. Rev. 123, 209-229, 1991.
23. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16, 34-38, 1995.
24. 24. Mosmann, T. R., and Moore, K. W., The role of IL-10 in crossregulation of Th1 and Th2 responses. Immunol. Today 12, A49-A53, 1991.
25. 25. Maeda, H., Kuwhara, H., Ichimura, Y., Ohtsuki, M., Kurakata, S., and Shiraishi, A., TGF-β enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J. Immunol. 155, 4926-4932, 1995.
26. 26. Maeda, H., and Shiraishi, A., TGF-β contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J. Immunol. 156, 73-78, 1996.
27. 27. Kehrl, J. G., Roberts, A. B., Wakefield, L. M., Jakowlew, S., Sporn, M. B., and Fauci, A. S., Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137, 3855-3860, 1986.
28. 28. Miyazono, K., Yuki, K., Takaku, F., Wernstedt, C., Kanzaki, T., Olofsson, A., Hellman, U., and Heldin, C-H., Latent forms of TGF-β: Structure and biology. Ann. N.Y. Acad. Sci. 593, 51-58, 1990.
29. 29. Miyazono, K., and Heldin, C. H., Latent forms of TGF-β: Molecular structure and mechanisms of activation. Ciba Found. Symp. 157, 81-92, 1991.
30. 30. Morrison, D. C., and Ryan, J. L., Endotoxins and disease mechanisms. Annu. Rev. Med. 38, 417-432, 1987.
31. 31. Plank, S. R., Huang, X. N., Robertson, J. E., and Rosenbaum, J. T., Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment. Invest. Ophthalmol. Vis. Sci. 35, 924-930, 1994.
32. 32. Glauser, M. P., Zanetti, G., Baumgartner, J.-D., and Cohen, J., Septic shock: Pathogenesis. Lancet 338, 732-736, 1991.
33. 33. Musso, T., Espinoza-Delgado, I., Pulkki, K., Gusella, G. L., Longo, D. L., and Varesio, L., Transforming growth factor β downregulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes. Blood 76, 2466-2469, 1990.